Patients Ponder on Filing Stryker Hip Lawsuit
Increased risk of metal poisoning or metallosis has been associated with the Stryker Rejuvenate hip replacement implant. The implant may not be a metal-on-metal hip replacement system, but it has parts made of titanium and cobalt which can be trigger metal poisoning in some patients. The Stryker Rejuvenate hip implant, according to reports, is also known for its high early failure rate. Instead of the estimated 15 years, the device starts to have problems in around five years or less. Because of this, some patients have contemplated on filing a Stryker hip lawsuit.
The Rejuvenate is different from other hip replacement devices. The implant has a ceramic component and is marketed for the use of younger patients as a modular hip replacement. The parts of the prosthetic hip are custo bm made to fit the user perfectly, resulting to a longer-lasting hip implant that offered a better range of motion.
Some patients allegedly began developing metallosis after the Rejuvenate was implanted into their body. At first, doctors and Stryker executives did not believe that such a condition was possible with the Rejuvenate because it did not have a metal-on-metal ball and socket design. Studies, though, found that its metal neck piece can rub against the metal stem under some conditions, thus causing metal debris to enter the bloodstream and attach onto surrounding tissues.
Stryker has replied to apprehensions about the Rejuvenate's early failure rate. The manufacturer claimed that the patients have not gone through proper rehabilitation. It also blamed doctors for whatever implantation technique they used when installing the hip replacement device.
Metallosis can cause adverse reaction in the implant's surrounding tissue. Heavy metal levels can also result to pseudotumors, limited mobility, DNA changes, dissolution of the bone, and chromosomal aberrations. The only possible solution for the negative effects is to have revision surgery, which is riskier and more painful than the initial operation.
On May 2012, Health Canada announced that the Rejuvenate will no longer be marketed in the country. A month and a half later, the Rejuvenate and another type of hip replacement system called ABG II drove Stryker to voluntarily recall the products. The Food and Drug Administration (FDA) received news on the events wherein a device was removed due to the health problems it has triggered. Reports of the device corroding and fretting also reached the FDA.
Some patients have sought legal counsel and want to file a Stryker hip lawsuit. So far, there have not been any cases against the Rejuvenate hip replacement system.
The Rejuvenate is different from other hip replacement devices. The implant has a ceramic component and is marketed for the use of younger patients as a modular hip replacement. The parts of the prosthetic hip are custo bm made to fit the user perfectly, resulting to a longer-lasting hip implant that offered a better range of motion.
Some patients allegedly began developing metallosis after the Rejuvenate was implanted into their body. At first, doctors and Stryker executives did not believe that such a condition was possible with the Rejuvenate because it did not have a metal-on-metal ball and socket design. Studies, though, found that its metal neck piece can rub against the metal stem under some conditions, thus causing metal debris to enter the bloodstream and attach onto surrounding tissues.
Stryker has replied to apprehensions about the Rejuvenate's early failure rate. The manufacturer claimed that the patients have not gone through proper rehabilitation. It also blamed doctors for whatever implantation technique they used when installing the hip replacement device.
Metallosis can cause adverse reaction in the implant's surrounding tissue. Heavy metal levels can also result to pseudotumors, limited mobility, DNA changes, dissolution of the bone, and chromosomal aberrations. The only possible solution for the negative effects is to have revision surgery, which is riskier and more painful than the initial operation.
On May 2012, Health Canada announced that the Rejuvenate will no longer be marketed in the country. A month and a half later, the Rejuvenate and another type of hip replacement system called ABG II drove Stryker to voluntarily recall the products. The Food and Drug Administration (FDA) received news on the events wherein a device was removed due to the health problems it has triggered. Reports of the device corroding and fretting also reached the FDA.
Some patients have sought legal counsel and want to file a Stryker hip lawsuit. So far, there have not been any cases against the Rejuvenate hip replacement system.
Source...